Lotti Dunne

Lotti Dunne has an extensive background in scientific research. Lotti started their career in 2017 as a New Business Development Executive at Optimum Results Ltd. In the same year, they also pursued their passion for scientific research as a PhD Researcher at The University of Auckland, where they focused on Motor Neuron Disease (MND). After completing their PhD in 2022, Lotti joined Helmholtz-Zentrum Hereon as a Postdoctoral Researcher until 2023. During their time there, they conducted research in collaboration with renowned scientists. Additionally, Lotti worked as a Cure Guide at Perlara PBC in 2022, contributing to the development of potential disease treatments. Lotti'slatest role is as a Research Scientist at Pantherna Therapeutics GmbH, where they specialize in the development of lipid nanoparticle mRNA delivery systems for specific tissues and cells. Lotti's work experience showcases their expertise in scientific research and their commitment to making advancements in the field.

Lotti Dunne began their education in 2013 at University College Dublin, where they pursued a Bachelor of Science degree in Neuroscience. Lotti successfully completed their undergraduate studies in 2017. Following this, Lotti pursued higher education at The University of Auckland starting from 2017. Over a period of four years, they obtained a Doctor of Philosophy degree in Neuroscience, completing their studies in 2021.